- 米国企業
- ADMA BIOLOGICS, INC.
ADMA BIOLOGICS, INC.ADMA
時価総額
$21億
PER
44.5倍
| 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
| Product Revenue | - | - | - | - | - | - | - | - | - | 81 | 154 | - |
| License Revenue | - | - | - | - | - | - | - | - | - | 142,834 | 142,834 | - |
| REVENUES | 1 | 3 | 6 | 7 | 11 | 23 | 17 | 29 | 42 | 81 | 154 | 258 |
| Cost of product revenue | 669,056 | 2 | 4 | 4 | 6 | 29 | 42 | 40 | 61 | 80 | 119 | 169 |
| Gross profit | 449,062 | 1 | 2 | 3 | 4 | -6,403,761 | -25,209,345 | -10,155,155 | -19,071,643 | 1 | 35 | 89 |
| Research and development | 3 | 9 | 10 | 7 | 8 | 6 | 4 | 2 | 6 | 4 | 4 | 3 |
| Plasma center operating expenses | 2 | 2 | 4 | 5 | 5 | 7 | 8 | 2 | 4 | 12 | 18 | 4 |
| Amortization of intangible assets | - | - | - | - | - | 1 | 844,938 | 844,938 | 715,353 | 1 | 1 | 1 |
| Selling, general and administrative | - | - | - | - | - | - | - | - | - | 43 | 52 | 59 |
| Total operating expenses | 8 | 18 | 22 | 23 | 28 | 62 | 77 | 71 | 107 | 60 | 75 | 67 |
| INCOME (LOSS) FROM OPERATIONS | -7,909,169 | -15,042,431 | -16,018,533 | -15,513,807 | -17,330,395 | -39,309,996 | -60,288,944 | -41,424,327 | -64,914,877 | -58,373,741 | -39,365,080 | 22 |
| Interest income | - | - | - | - | - | - | - | - | 288,126 | 34,532 | 44,833 | 2 |
| Interest expense | 30,683 | 618,225 | 1 | 2 | 2 | 3 | 6 | 9 | 12 | 13 | 19 | 25 |
| Loss on extinguishment of debt | - | - | - | -719,097 | - | -1,210,216 | - | -9,962,495 | 991,797 | - | -6,669,941 | -26 |
| Other expense | - | - | - | - | - | -10,144 | -127,121 | -227,322 | -128,528 | -251,575 | -634,389 | -0 |
| Other expense, net | - | -484,815 | -1,346,354 | -2,456,123 | -2,184,756 | -4,448,979 | -5,454,501 | -6,854,990 | -10,833,671 | -13,273,877 | -26,538,870 | -50 |
| NET LOSS | -7,301,313 | -15,527,246 | -16,813,163 | -17,969,930 | -19,515,151 | -43,758,975 | -65,743,445 | -48,279,317 | -75,748,548 | -71,647,618 | -65,903,950 | -28 |
| BASIC LOSS PER COMMON SHARE (in dollars per share) | - | - | - | - | - | - | - | - | - | -0.51 | -0.33 | -0.13 |
| DILUTED LOSS PER COMMON SHARE (in dollars per share) | - | - | - | - | - | - | - | - | - | -0.51 | -0.33 | -0.13 |
| Product Revenue | - | - | - | - | - | - | - | - | - | 81 | 154 | - |
| License Revenue | - | - | - | - | - | - | - | - | - | 142,834 | 142,834 | - |
| REVENUES | 1 | 3 | 6 | 7 | 11 | 23 | 17 | 29 | 42 | 81 | 154 | 258 |
| Cost of product revenue | 669,056 | 2 | 4 | 4 | 6 | 29 | 42 | 40 | 61 | 80 | 119 | 169 |
| Gross profit | 449,062 | 1 | 2 | 3 | 4 | -6,403,761 | -25,209,345 | -10,155,155 | -19,071,643 | 1 | 35 | 89 |
| Research and development | 3 | 9 | 10 | 7 | 8 | 6 | 4 | 2 | 6 | 4 | 4 | 3 |
| Plasma center operating expenses | 2 | 2 | 4 | 5 | 5 | 7 | 8 | 2 | 4 | 12 | 18 | 4 |
| Amortization of intangible assets | - | - | - | - | - | 1 | 844,938 | 844,938 | 715,353 | 1 | 1 | 1 |
| Selling, general and administrative | - | - | - | - | - | - | - | - | - | 43 | 52 | 59 |
| Total operating expenses | 8 | 18 | 22 | 23 | 28 | 62 | 77 | 71 | 107 | 60 | 75 | 67 |
| INCOME (LOSS) FROM OPERATIONS | -7,909,169 | -15,042,431 | -16,018,533 | -15,513,807 | -17,330,395 | -39,309,996 | -60,288,944 | -41,424,327 | -64,914,877 | -58,373,741 | -39,365,080 | 22 |
| Interest income | - | - | - | - | - | - | - | - | 288,126 | 34,532 | 44,833 | 2 |
| Interest expense | 30,683 | 618,225 | 1 | 2 | 2 | 3 | 6 | 9 | 12 | 13 | 19 | 25 |
| Loss on extinguishment of debt | - | - | - | -719,097 | - | -1,210,216 | - | -9,962,495 | 991,797 | - | -6,669,941 | -26 |
| Other expense | - | - | - | - | - | -10,144 | -127,121 | -227,322 | -128,528 | -251,575 | -634,389 | -0 |
| Other expense, net | - | -484,815 | -1,346,354 | -2,456,123 | -2,184,756 | -4,448,979 | -5,454,501 | -6,854,990 | -10,833,671 | -13,273,877 | -26,538,870 | -50 |
| NET LOSS | -7,301,313 | -15,527,246 | -16,813,163 | -17,969,930 | -19,515,151 | -43,758,975 | -65,743,445 | -48,279,317 | -75,748,548 | -71,647,618 | -65,903,950 | -28 |
| BASIC LOSS PER COMMON SHARE (in dollars per share) | - | - | - | - | - | - | - | - | - | -0.51 | -0.33 | -0.13 |
| DILUTED LOSS PER COMMON SHARE (in dollars per share) | - | - | - | - | - | - | - | - | - | -0.51 | -0.33 | -0.13 |